DENTSPLY SIRONA Inc. $XRAY Holdings Boosted by Sound Income Strategies LLC

Sound Income Strategies LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 32.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 611,308 shares of the medical instruments supplier’s stock after acquiring an additional 149,384 shares during the period. Sound Income Strategies LLC’s holdings in DENTSPLY SIRONA were worth $7,464,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of XRAY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in DENTSPLY SIRONA in the first quarter worth about $26,000. Huntington National Bank lifted its holdings in DENTSPLY SIRONA by 292.9% in the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 2,077 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in DENTSPLY SIRONA by 337.9% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 2,122 shares during the last quarter. True Wealth Design LLC raised its holdings in shares of DENTSPLY SIRONA by 49.7% during the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock valued at $45,000 after buying an additional 1,181 shares during the last quarter. Finally, Central Pacific Bank Trust Division raised its holdings in shares of DENTSPLY SIRONA by 100.0% during the third quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 2,000 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $11.64 on Tuesday. DENTSPLY SIRONA Inc. has a 12 month low of $9.85 and a 12 month high of $17.18. The stock has a market cap of $2.33 billion, a price-to-earnings ratio of -3.88, a PEG ratio of 1.37 and a beta of 0.99. The stock’s 50 day moving average price is $12.45 and its 200 day moving average price is $12.11. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.51 and a quick ratio of 1.03.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The firm had revenue of $961.00 million for the quarter, compared to the consensus estimate of $926.40 million. During the same period in the previous year, the firm earned $0.26 EPS. DENTSPLY SIRONA’s revenue for the quarter was up 6.2% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on XRAY. Zacks Research raised DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a report on Monday, March 2nd. Barrington Research lifted their price target on DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a report on Monday, March 2nd. Robert W. Baird lifted their price target on DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a report on Friday, February 27th. Wells Fargo & Company lifted their price target on DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus price target of $14.42.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director James D. Forbes purchased 5,000 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were purchased at an average price of $12.48 per share, for a total transaction of $62,400.00. Following the completion of the transaction, the director owned 10,000 shares in the company, valued at $124,800. This represents a 100.00% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gregory T. Lucier purchased 27,555 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was acquired at an average price of $14.24 per share, for a total transaction of $392,383.20. Following the transaction, the director owned 27,555 shares of the company’s stock, valued at $392,383.20. The trade was a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders acquired 70,000 shares of company stock worth $956,437. 0.50% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.